Massachusetts Financial Services Co. MA Boosts Position in Waters Corporation $WAT

by · The Markets Daily

Massachusetts Financial Services Co. MA raised its holdings in shares of Waters Corporation (NYSE:WAT – Free Report) by 44.3% during the third quarter, HoldingsChannel reports. The institutional investor owned 2,689,693 shares of the medical instruments supplier’s stock after acquiring an additional 825,723 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Waters were worth $806,397,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Brighton Jones LLC raised its stake in shares of Waters by 112.9% during the fourth quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after purchasing an additional 673 shares during the period. Integrated Wealth Concepts LLC grew its holdings in Waters by 2.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after purchasing an additional 30 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in Waters by 3.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock worth $73,733,000 after buying an additional 6,976 shares during the period. Empowered Funds LLC lifted its holdings in Waters by 16.6% in the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after buying an additional 160 shares in the last quarter. Finally, Parallel Advisors LLC boosted its position in Waters by 5.3% in the 2nd quarter. Parallel Advisors LLC now owns 849 shares of the medical instruments supplier’s stock valued at $296,000 after buying an additional 43 shares during the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Performance

Shares of WAT opened at $387.07 on Friday. The stock has a market capitalization of $23.05 billion, a PE ratio of 35.58, a price-to-earnings-growth ratio of 3.24 and a beta of 1.16. The business’s fifty day moving average price is $389.30 and its 200 day moving average price is $340.42. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.53 and a quick ratio of 1.08. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56.

Waters (NYSE:WAT – Get Free Report) last released its earnings results on Tuesday, November 4th. The medical instruments supplier reported $3.40 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.19. The firm had revenue of $799.89 million during the quarter, compared to analyst estimates of $780.05 million. Waters had a net margin of 20.89% and a return on equity of 36.59%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.93 earnings per share. Waters has set its FY 2025 guidance at 13.050-13.150 EPS and its Q4 2025 guidance at 4.450-4.550 EPS. Equities research analysts forecast that Waters Corporation will post 12.86 EPS for the current year.

Wall Street Analyst Weigh In

WAT has been the topic of a number of analyst reports. Rothschild & Co Redburn started coverage on Waters in a research report on Wednesday, October 8th. They set a “buy” rating and a $390.00 target price on the stock. TD Cowen lifted their price objective on Waters from $345.00 to $390.00 and gave the stock a “hold” rating in a report on Wednesday, November 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a research note on Wednesday, October 8th. Cowen restated a “hold” rating on shares of Waters in a research note on Wednesday, November 5th. Finally, Wolfe Research upgraded shares of Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 price objective on the stock in a research note on Wednesday, December 10th. Two research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, Waters presently has an average rating of “Moderate Buy” and a consensus price target of $395.00.

Check Out Our Latest Analysis on Waters

Waters Profile

(Free Report)

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.

Featured Articles

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT – Free Report).